Daiwa Securities Group Inc. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$01020.0%0.00%
Q2 2021$01020.0%0.00%
Q1 2021$0
-100.0%
1020.0%0.00%
Q4 2020$1,0000.0%102
-40.0%
0.00%
Q3 2020$1,0001700.0%0.00%
Q2 2020$01700.0%0.00%
Q1 2020$0
-100.0%
1700.0%0.00%
Q4 2019$1,000
-50.0%
1700.0%0.00%
Q3 2019$2,0000.0%1700.0%0.00%
Q2 2019$2,0000.0%1700.0%0.00%
Q1 2019$2,000
-60.0%
170
-43.3%
0.00%
Q4 2018$5,0003000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Crawford Lake Capital Management, LLC 72,493$4,160,0000.63%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,583,291$18,212,0000.58%
Redmile Group, LLC 3,000,641$21,155,0000.51%
ArrowMark Colorado Holdings LLC 1,928,308$13,595,0000.12%
IHT Wealth Management, LLC 90,675$639,0000.08%
GSA CAPITAL PARTNERS LLP 47,578$335,0000.04%
Blackstone Inc. 450,000$3,173,0000.02%
Crawford Lake Capital Management, LLC 2,000$115,0000.02%
MOORE CAPITAL MANAGEMENT, LP 50,000$353,0000.01%
CITIGROUP INC 2,201,839$15,523,0000.01%
View complete list of XERIS PHARMACEUTICALS INC shareholders